ZNF345 activators encompass a group of chemical compounds that, although not directly interacting with ZNF345, indirectly modulate its function within the cellular milieu. ZNF345, classified as a zinc-finger protein, is intricately involved in transcriptional regulation. This regulatory function means that changes in the chromatin environment, particularly alterations to histone modification or DNA methylation, can influence ZNF345's ability to bind to DNA and regulate gene expression. Histone deacetylase (HDAC), such as trichostatin A, vorinostat, and mocetinostat, act by the removal of acetyl groups from histone proteins. This inhibition maintains chromatin in a more open conformation, allowing transcription factors, including ZNF345, easier access to DNA. This increased accessibility can enhance ZNF345's ability to bind to its target DNA sequences and regulate the associated genes. Similarly, DNA methyltransferase like 5-Aza-2'-deoxycytidine and RG108, which reduce the methylation of cytosine residues in DNA, can activate genes silenced due to hypermethylation. The activation of such genes can, in some contexts, be mediated by transcription factors like ZNF345 if they are part of its regulatory network.
Another key class of compounds within ZNF345 activators are the G9a/GLP histone methyltransferase, including BIX 01294 and UNC0638. By inhibiting the addition of methyl groups to specific lysine residues on histones, these compounds affect the epigenetic markers that govern gene expression. Such changes in the histone methylation landscape can have downstream effects on the ability of transcription factors like ZNF345 to bind to DNA and regulate gene expression. In essence, the chemical class termed ZNF345 activators underlines the concept that transcriptional regulation isn't solely dependent on the direct interactions between a transcription factor and its binding sites on DNA. It also relies heavily on the chromatin environment, which can be modulated by various chemicals, leading to indirect effects on transcription factors, including ZNF345. These activators thus offer a lens through which the intricacies of epigenetic regulation and its influence on transcription factors can be better understood, emphasizing the interplay between chemical compounds, chromatin modifications, and the resultant impact on proteins like ZNF345.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that changes chromatin structure, possibly influencing ZNF345's binding and activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor. By altering chromatin accessibility, it can indirectly modulate ZNF345's interaction with target DNA sequences. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
Inhibits G9a histone methyltransferase, potentially modifying ZNF345's transcriptional regulatory activity due to altered histone methylation patterns. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
HDAC inhibitor that can influence chromatin structure and subsequently modulate ZNF345's DNA-binding capacity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor affecting chromatin conformation. This alteration can change how ZNF345 interacts and regulates its target genes. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
G9a/GLP histone methyltransferase inhibitor. Its action on histone methylation can indirectly influence ZNF345's transcriptional regulation. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
DNA methyltransferase inhibitor. By changing DNA methylation patterns, it may indirectly modulate ZNF345's activity. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
HDAC inhibitor affecting chromatin accessibility, possibly influencing ZNF345's binding and regulatory function. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Pan-HDAC inhibitor, which can modulate chromatin structure and indirectly affect ZNF345's DNA-binding and regulatory functions. | ||||||
UNC 0642 | 1481677-78-4 | sc-397059 | 10 mg | $235.00 | 3 | |
Inhibits G9a/GLP histone methyltransferase. By altering histone methylation, it may modulate ZNF345's transcriptional regulation. | ||||||